The WVU Cancer Institute (WVUCI) Bridge Program implements a comprehensive survivorship program for stage 1-3 lung cancer patients completing curative treatment. The ultimate goal is to improve coordination of care, increase quality of life, and decrease the consequences of treatment. In this analysis, we summarize the program outcomes and provide an economic perspective on implementation and sustainability. The Bridge Program enrolls and assesses patients at the end of cancer treatment using a multidisciplinary team approach. Patients diagnosed with late stage lung cancer are often referred to supportive or palliative care programs that provide symptom management, psychosocial support and follow up, and advanced planning. In contrast, the needs of patients diagnosed at a curable stage often go unaddressed. The Program’s goal is to improve patient quality of life in physical, social, psychological, and spiritual domains. It ultimately bridges patients from active cancer care to the next step on their journey in life. Using a multidisciplinary team approach creates an opportunity for collaboration and information sharing that leads to the development of an enhanced survivorship care plan. Between March 2017 and June 2019, the Program enrolled 81 patients across three locations. At the end of cancer care, 100% of these patients had at least one unmet need and nearly half had seven or more. Assessment identified a total of 540 unmet needs which resulted in 132 clinician referrals. When categorizing unmet needs into physical, practical, and emotional domains, Bridge patients identified more unmet needs in the physical category than any other. The most common referrals were for Physical Therapy and Occupational Therapy. Following enrollment, 93% of Bridge patients showed a decrease in the number of unmet needs at their first recurrence and monitoring visit. Given the comprehensive approach of the program, there are a variety of financial implications to consider in sustaining and expanding its reach. Based on patient outcomes, we estimated personnel costs and referral generation revenue in determining the long-term sustainability. Estimated fees and billable amounts for referrals were reviewed against values in the HealthCare BlueBook. The estimated revenue generated seems to offset the costs of implementation of the program with a potential 50% return on investment, while addressing a critical gap in care for WVUCI lung cancer patients.